Jacob Logan
Researchers from the Abramson Cancer Center of the University of Pennsylvania have found that liquid biopsy can help to predict the prognosis of glioblastoma(GBM), the most aggressive and common brain cancer in adults.
The study indicated that patients with a higher concentration of cfDNA have shorter progression-free survival than those with less cfDNA.
Furthermore, cfDNA increases in patients either at the time of or just before their disease progresses.
Liquid biopsy was compared with the genetic sequencing of solid tissue biopsies in GBM cases.
Both biopsies detected the genetic mutations in over half of the patients and none of the mutations overlapped, indicating that the liquid biopsy may provide complementary information about the genetic constitution of each tumour.
An estimated 11,000 cases of GBM are diagnosed every year, with a five-year survival rate between 5 and 10%.
0
Jacob Logan
Related Articles
Compared to traditional tissue biopsy, liquid biopsy is minimally invasive, convenient for patients and repeated sampling for monitoring disease progression and therapeutic response is possible. The global liquid biopsy market is estimated to be valued at US$ 5. Threat of new substitutes: The threat from new substitutes is moderate since liquid biopsy is advantageous over other traditional diagnostic methods. The global Liquid Biopsy Market is estimated to be valued at US$ 5. North America dominates the global market due to rapid adoption of advanced technologies and presence of key market players in the region.
0
In the world of medical diagnostics, liquid biopsy has emerged as a groundbreaking technology, especially in the field of cancer detection. The global liquid biopsy market's staggering growth shows a revenue close to US$4 Bn in 2021, with an impressive CAGR of 17. According to Fairfield Market Research, this market is expected to reach a valuation of US$15. Growing Need for Liquid Biopsy in Cancer DetectionCancer, being the second leading cause of death globally, is seeing a surge in incidence. Conclusion: The Future of Liquid Biopsy MarketWith an impressive projected growth rate and a multitude of applications, the liquid biopsy market is positioned to revolutionize cancer diagnostics.
0
The global liquid biopsy market is projected to reach $19. 83%, reveals the premium market intelligence study by BIS Research. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives. Analyst's Take on the Market:According to Nitish Kumar Singh, Principal Analyst – BIS Research, states, "North America is the leading contributor in the global liquid biopsy market. "View the report from BIS Research on Global Liquid Biopsy MarketKey Companies Operating in the Market and Competition LandscapeKey insights are drawn from in-depth interviews with the key opinion leaders of 6 leading companies, market participants, and vendors.
0
Major Players of Global liquid biopsy market:The major participants of this market are: Guardant Health, Inc. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample. Regional Analysis:Depending on geographic region, Liquid biopsy market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. com/reports/liquid-biopsy-marketAbout Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
0
Other types of liquid biopsy can involve analyzing other bodily fluids such as urine, saliva, or cerebrospinal fluid. Monitoring cancer progression: Liquid biopsy can be used to monitor the progression of cancer and track the effectiveness of treatment. According to a report by BIS Research, the global liquid biopsy market size was valued at $2,508. As the technology continues to improve and become more widely adopted, we can expect to see continued growth in the liquid biopsy market. Get Free Sample Report on Liquid Biopsy Market - Click HereConclusionLiquid biopsy is a promising new technology that has the potential to revolutionize cancer diagnosis and treatment.
0
The cumulative force of these factors is projected to unlock tremendous growth opportunities for the global liquid biopsy market. In addition to this, the rising investments in developing advanced medical products and devices, and a surge in demand for minimally invasive surgical procedures is driving the liquid biopsy market growth. Such a landscape is anticipated to holistically expand the global liquid biopsy market over the forecasted period. This, in turn, drives the global liquid biopsy market toward fruition. ContactFairfield Market ResearchLondon, UKUK +44 (0)20 30025888 USA (Toll-free) +1 (844) 3829746 Web: https://www.
0
